receives

DuPont's first biologically derived polymer receives global recognition

DuPont's newest polymer innovation, the first DuPont polymer derived from a biological source, has been recognized by the China State Intellectual Property Office and China Central Television (CCTV) as "Most Visionary Innovation" at a recent award ceremony. will receive the 2005 "New Technologies in Re...

OneWorld Health drug receives 'Orphan' designation from U.S. and European regulatory agencies

The Institute for OneWorld Health, the first nonprofit pharmaceutical company in the U.S., announced today it has received Orphan Drug Designation from the two leading regulatory agencies in the world, the Food and Drug Administration (FDA) and the European Agency for the Evaluation of Medicinal Products (EMEA), for paromomycin to treat visceral leishmaniasis (VL). VL, also known as kala a...

Research on antibiotics receives historical recognition

Research leading to the discovery of streptomycin ?the first effective pharmaceutical treatment for tuberculosis ?will be designated a National Historic Chemical Landmark at Rutgers University in a special ceremony in New Brunswick, New Jersey, on May 24. The American Chemical Society, the world's largest scientific society, sponsors the landmarks program. Beginning in the 1930s, Selman Wa...

Anthrax test, developed by army and CDC, receives FDA approval

A method for identifying Bacillus anthracis, the causative agent of anthrax, has been cleared for diagnostic use by the U.S. Food and Drug Administration (FDA). The test, known as the Gamma Phage Assay, was modified by scientists at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) to improve its performance and reliability when used with clinical specimens. The original...

Research team receives $7.5 million to study cassava

Ohio State University will lead an interdisciplinary team of scientists in a multi-million dollar project to help improve one of the most important food crops in Africa, cassava. The Bill and Melinda Gates Foundation selected the BioCassava Plus project as a recipient of one of the foundation's "Grand Challenges in Global Health" program grants. Created two years ago, the goal of the $450...

receives at Biology Products

No data found

Search receives biology products at Google

Search receives biology products at Yahoo

Search receives biology products at Msn

receives at Biology Technology

Platypus Technologies receives $1.6 million NIH grant

The Small Business Innovation Research grant is for continued development of the company's proprietary liquid crystal based technology to enable faster screening of drugs for treatment of cancer. The com...

Third Wave receives FDA clearance of pharmacogenetic test

It is the first pharmacogenetic test to be approved by the FDA for use as a companion diagnostic to a specific drug therapy. The test is c...

Medical College receives $377K to study brain disease

The research, which will be led by principal investigator Jeannette Vasquez Vivar, assistant professor of...

Lucigen receives $750K grant to boost biofuel yields

The product is the company's second bioprospecting find as the result of d...

Medical College receives $1.4M cancer grant

This is the second successful renewal of the grant that was first awarded in 2003. Kathleen Schmainda, associate professor o...

More>>

receives at Medicine News

Infant receives first bloodless liver transplant

An Iowa infant aged 7 months was the first recipient of a bloodless liver transplant in Los Angeles, the United States of America. The seven month old, Aiden Michael Rush, whose parents are Jehovah’s Witnesses are prohibited by their religion to receive transfusions. The boy received 20% of his mother’s liver during the transplantation on February 7th at the children’s hospital i...

Fifth US Patient Receives Artificial Heart

A fifth man has received a self-contained artificial heart, but he is having problems with his lungs, surgeons at Hahnemann University Hospital in Philadelphia, Pennsylvania, said. The medical team said details about the patient would be released later. Surgeons have said previously that patients considered for the implant must be critically ill with fewer than 30 days to live. // "Th...

Northfield Labs Receives FDA Comments

Northfield Laboratories, founded in 1985, is a leading developer of an oxygen-carrying blood substitute. Its product, PolyHeme, is the only blood substitute undergoing clinical trials that has been tested at large enough dosages to be considered a substitute for acute blood loss in trauma and surgical settings. As a result of the process used to manufacture the blood substitute, essential...

British MPs Say Prostate Cancer Receives Low Priority in the NHS

The House of Commons public accounts committee (PAC) in the UK has severely criticized the NHS for failing to supply accurate information about cancer to patients. The committee also castigated the NHS for according a low priority to prostate cancer as compared to some other cancers. // The report also said that most terminally ill cancer patients were not aware of disability benefits th...

Abbott Receives CE Mark Certification

The CE Mark certification has been received by the global healthcare company Abbott towards a new test for detecting the Neissera gonorrhoeae (NG) and Chlamydia trachomatis // (CT) sexually transmitted pathogens. This will enable the company to sell the product in the European Union (EU). The test will be conducted through the Abbott m2000?, which uses real time polymerase chain reaction...

More>>

receives at Medicine Products

No data found

Search receives medicine products at Google

Search receives medicine products at Yahoo

Search receives medicine products at Msn

receives at Medicine Technology

Sirion Therapeutics Receives Orphan Drug Designation for Ophthalmic Drug to Treat Viral Eye Infection

TAMPA, Fla., April 16, 2007 /PRNewswire/ -- Sirion Therapeutics,Inc., an ophthalmic-focused biopharmaceutical company, announcedtoday that it has received orphan drug designation from the Foodand Drug Administration (FDA) for its anti-viral therapy,ganciclovir, for the treatment of acute herpetic keratitis. Theproduct is currently marketed by Laboratoires Thea in Europe underthe brand na...

Protalix BioTherapeutics, Inc. Receives Approval from the FDA to Initiate a Phase III Clinical Trial of prGCD

Phase III clinical trial may commence shortly CARMIEL, Israel, April 18, 2007 /PRNewswire-FirstCall/ ---Protalix BioTherapeutics, Inc. today announced that it has receivedwritten notice from the United States Food and Drug Administration(FDA) that it may initiate a Phase III clinical trial in the UnitedStates of its lead product candidate, prGCD, a proprietary plantcell expressed recombin...

DUSA Pharmaceuticals Receives Orphan Drug Desi gnation for Levulan PDT to Treat Esophage al Dysplasia

Researchers' Study Shows Promising Treatment for People Sufferingfrom Barrett's Esophagus, a Leading Cause of Esophageal Cancer WILMINGTON, MASSACHUSETTS--(CCNMatthews - May 17, 2007) - DUSAPharmaceuticals, Inc. (NASDAQ GM:DUSA) announced that the U.S. Foodand Drug Administration (FDA) has granted Orphan Drug Designationfor Levulan(R) (aminolevulinic acid HCl) Photodynamic Therapy (PDT)fo...

Gloucester Pharmaceuticals Receives Fast Track Designation for Romidepsin in Peripheral T-Cell Lymphoma

CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 16, 2007 - GloucesterPharmaceuticals, Inc., an oncology focused biopharmaceuticalcompany, announced today that the U.S. Food and Drug Administration(FDA) has granted Fast Track designation for its novel histonedeacetylase inhibitor, romidepsin, for the monotherapy ofpreviously treated peripheral T-cell lymphoma (PTCL). The Companyhad previously announc...